Preoperative lymphocyte-to-monocyte ratio predicts postoperative infectious complications after laparoscopic
Tunyaporn Kamonvarapitak1,2, Akihisa Matsuda3, Satoshi Matsumoto1
1Department of Surgery, Nippon Medical School Chiba Hokusoh Hospital, 1715 Kamagari, Inzai, Chiba, 270-1694, Japan.
Background And Aim:
Postoperative infectious complications (POI), which can increase length of hospital stay, medical cost, and worsen overall survival, are a concern in minimally invasive colorectal cancer (CRC) surgeries. Recent reports showed that relatively new inflammation-based score, lymphocyte-to-monocyte ratio (LMR) is an independent predictor of long-term outcomes after CRC surgeries. In this study, LMR was evaluated as a predictor of short-term postoperative outcomes.
Patients And Methods:
This was a single-institutional retrospective study of 211 consecutive patients who had undergone laparoscopic CRC surgery with primary tumor resection from January 2014 to August 2015 at Nippon Medical School Chiba Hokusoh Hospital. The patients were divided into two groups (no POI; n = 176 and POI; n = 35). The associations between inflammation-based scores, namely neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and LMR, and the occurrence of POI were investigated. Receiving operator characteristic curve analysis was used to determine the cutoff point of preoperative LMR.
Results:
Low LMR (cut-off 3.46), long operative time, and smoking were found to be independent predictors of POI in a multivariate analysis (LMR: Odds ratio 5.61, 95% confidence interval 1.98-15.9, P = 0.001). Patients with low LMR also appeared to have more advanced and aggressive tumours.
Conclusion:
This is the first study to report that the lower LMR is a predictive factor of POI after laparoscopic CRC surgery, and it may provide additional information for treatment decisions to prevent POI.
Insights
A low lymphocyte-to-monocyte ratio (LMR) predicts postoperative infectious complications (POI) after colorectal cancer (CRC) surgery. This finding may help guide treatment decisions to prevent POI in patients undergoing minimally invasive CRC surgery.
Area of Science:
- Oncology
- Surgical Oncology
- Inflammation Biomarkers
Background:
- Postoperative infectious complications (POI) are a significant concern in minimally invasive colorectal cancer (CRC) surgery, impacting hospital stay, costs, and survival.
- Inflammation-based scores, particularly the lymphocyte-to-monocyte ratio (LMR), have emerged as potential predictors of long-term outcomes in CRC patients.
Purpose of the Study:
- To evaluate the lymphocyte-to-monocyte ratio (LMR) as a predictor of short-term postoperative infectious complications (POI) following laparoscopic colorectal cancer (CRC) surgery.
- To investigate the association between preoperative LMR and the occurrence of POI in patients undergoing CRC resection.
Main Methods:
- A retrospective study of 211 patients who underwent laparoscopic CRC surgery.
- Patients were categorized into groups with and without POI.
- Inflammation-based scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, LMR) were analyzed; receiver operating characteristic curve analysis determined the LMR cutoff point.
Main Results:
- Low LMR (cutoff 3.46) was identified as an independent predictor of POI (Odds ratio 5.61, P=0.001), alongside long operative time and smoking.
- Patients with a low LMR exhibited more advanced and aggressive tumors.
- Multivariate analysis confirmed LMR as a significant predictor of POI.
Conclusions:
- This study is the first to demonstrate that a lower lymphocyte-to-monocyte ratio (LMR) is a predictive factor for postoperative infectious complications (POI) after laparoscopic CRC surgery.
- Preoperative LMR assessment may offer valuable insights for treatment decisions aimed at preventing POI.
- The findings highlight the potential utility of LMR in risk stratification for patients undergoing minimally invasive CRC surgery.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
08:26Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
Published on: March 24, 2023
